NanoString Technologies Inc (NASDAQ:NSTG) is expected to release quarterly earnings data after market close on Tuesday, March 1. Analysts expect the company to report earnings of ($0.56) per share for the quarter. Parties wishing to register for the company’s conference call may do so using this link.
Shares of NanoString Technologies opened at $31.72 on Tuesday. NanoString Technologies has a 1-year low of $30.16 and a 1-year high of $83.01. The company has a debt ratio of 1.13, a current ratio of 10.03 and a quick ratio of 9.33. The stock’s 50-day moving average is $36.64 and its 200-day moving average is $44.86. The company has a market capitalization of $1.45 billion, a price/earnings ratio of -13.00 and a beta of 1.73.
Several brokerages have published reports on NSTG. Zacks Investment Research downgraded NanoString Technologies from a “buy” rating to a “hold” rating in a Thursday, January 13 report. Robert W. Baird cut his price target on NanoString Technologies from $71.00 to $60.00 and set an “outperform” rating for the company in a Wednesday, November 10 research report. Two equity research analysts gave the stock a hold rating and three gave the company a buy rating. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $62.40.
Institutional investors have recently been buying and selling shares of the company. Stifel Financial Corp increased its holdings of NanoString Technologies shares by 71.7% in the fourth quarter. Stifel Financial Corp now owns 7,557 shares of the biotech company worth $319,000 after acquiring 3,155 additional shares during the period. Allstate Corp increased its holdings of NanoString Technologies shares by 20.7% in the fourth quarter. Allstate Corp now owns 7,718 shares of the biotech company worth $326,000 after acquiring 1,322 additional shares during the period. BNP Paribas Arbitrage SA increased its equity stake in NanoString Technologies by 383.0% in the third quarter. BNP Paribas Arbitrage SA now owns 8,187 shares of the biotech company worth $393,000 after acquiring an additional 6,492 shares during the period. Jane Street Group LLC increased its stake in NanoString Technologies by 209.8% during the third quarter. Jane Street Group LLC now owns 15,031 shares of the biotech company valued at $722,000 after purchasing an additional 10,179 shares during the period. Finally, LPL Financial LLC increased its stake in NanoString Technologies by 11.8% during the third quarter. LPL Financial LLC now owns 16,190 shares of the biotech company valued at $777,000 after purchasing an additional 1,715 shares during the period.
NanoString Technologies Company Profile
NanoString Technologies, Inc. engages in the development and commercialization of instruments and services for gene and protein profiling from tissue samples. It offers the GeoMx Digital Spatial Profiler and nCounter Analysis System product platforms, both of which include instruments, associated consumables and software.
This instant news alert was powered by MarketBeat’s storytelling science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in NanoString Technologies right now?
Before you consider NanoString Technologies, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated, top-performing research analysts daily and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off… and NanoString Technologies didn’t make the list.
Although NanoString Technologies currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here